Results 1 to 10 of about 1,354 (149)

The role of brimonidine tartrate gel in the treatment of rosacea [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology, 2015
J Mark Jackson,1 Melissa Knuckles,2 John Paul Minni,3 Sandra Marchese Johnson,4, Kevin Tate Belasco5 1Division of Dermatology, University of Louisville, Louisville, KY, USA; 2PSC, Dermatology, Corbin, KY, USA; 3Waters Edge Dermatology, Stuart, FL, USA ...
J Mark Jackson
exaly   +9 more sources

Effect of brimonidine tartrate on basophil activation in glaucoma patients [PDF]

open access: yesInternational Journal of Ophthalmology, 2020
AIM: To evaluate the mechanism of which brimonidine tartrate 0.15% causes clinical hypersensitivity. METHODS: A prospective case-control study comparing 8 glaucoma patients with clinical hypersensitivity to brimonidine to a control group consisting 13 ...
Eldar Rosenfeld   +7 more
doaj   +4 more sources

Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use [PDF]

open access: yesCase Reports in Ophthalmological Medicine, 2023
Lipid keratopathy (LK) is a rare disease involving lipid deposition in the cornea resulting in corneal opacification. Primary LK can arise sporadically while secondary LK is seen in patients with a history of ocular trauma, medication exposure, infection,
Majid Moshirfar   +6 more
doaj   +5 more sources

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics [PDF]

open access: yesFrontiers in Medicine, 2023
AimsTo investigate the differences between 0.2 and 0.15% brimonidine tartrate eye drops for anti-mydriatic effects and the optical quality under different light conditions.MethodsThis prospective study involved 80 consecutive high myopia patients ...
Wang Weiqun
exaly   +4 more sources

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery [PDF]

open access: yesPharmaceuticals, 2023
Brimonidine tartrate (BRT) is a highly selective α2 adrenergic receptor agonist as treatment for patients with open angle glaucoma and high intraocular pressure.
Zhan Tang
exaly   +4 more sources

Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study [PDF]

open access: yesDrug Delivery, 2019
Brimonidine tartrate (BRT) is a hydrophilic α2 adrenergic agonist used for the treatment of glaucoma. Glaucoma is an ocular disease affecting the anterior segment of the eye requiring lifetime treatment.
Alaa Emad Eldeeb, Salwa Salah
exaly   +3 more sources

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study. [PDF]

open access: yesPLoS ONE, 2022
PurposeTo evaluate the concentrations of brimonidine and timolol in the vitreous and aqueous humors after instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution.MethodsThis single-arm open-label interventional ...
Yusuke Orii   +7 more
doaj   +3 more sources

Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial [PDF]

open access: yesScientific Reports, 2023
This multicenter (four institutions), randomized, investigator-masked, parallel-group clinical trial evaluated and compared the efficacy and safety of preservative-free and preserved brimonidine tartrate 0.15% in open-angle glaucoma and ocular ...
Ko Eun Kim   +4 more
doaj   +2 more sources

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops [PDF]

open access: yesGMS Ophthalmology Cases, 2020
Objective: We report three cases of preterm neonates who presented with central nervous system (CNS) and respiratory depression after inadvertent exposure to brimonidine tartrate 0.2% and timolol maleate 0.5% fixed-combination ophthalmic drops.Case ...
Azarcon, Corrina P., Santiago, Darby E.
doaj   +2 more sources

A novel reversed phase high performance liquid chromatography approach for stability-indicating simultaneous analysis of brimonidine tartrate and timolol maleate [PDF]

open access: yesFrontiers in Chemistry
IntroductionThe simultaneous quantification of Brimonidine Tartrate and Timolol Maleate in ophthalmic formulations is essential for ensuring product quality, efficacy, and stability.
Aktham Mestareehi, Aktham Mestareehi
doaj   +2 more sources

Home - About - Disclaimer - Privacy